NALDINI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 18.636
EU - Europa 15.074
AS - Asia 8.503
SA - Sud America 1.222
AF - Africa 361
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 11
Totale 43.841
Nazione #
US - Stati Uniti d'America 18.385
CN - Cina 3.258
GB - Regno Unito 3.177
SG - Singapore 2.761
RU - Federazione Russa 2.720
IT - Italia 2.013
IE - Irlanda 1.932
UA - Ucraina 1.267
SE - Svezia 1.089
BR - Brasile 1.016
DE - Germania 998
FR - Francia 975
VN - Vietnam 650
HK - Hong Kong 606
FI - Finlandia 511
KR - Corea 447
IN - India 212
ZA - Sudafrica 191
CA - Canada 118
BD - Bangladesh 112
MX - Messico 85
TR - Turchia 77
ES - Italia 71
AR - Argentina 70
JP - Giappone 70
IQ - Iraq 55
NL - Olanda 52
PL - Polonia 51
PK - Pakistan 43
EC - Ecuador 38
CZ - Repubblica Ceca 37
AU - Australia 31
MA - Marocco 30
NG - Nigeria 30
BE - Belgio 28
AT - Austria 26
UZ - Uzbekistan 24
VE - Venezuela 24
ID - Indonesia 23
CL - Cile 22
CO - Colombia 22
KE - Kenya 22
CI - Costa d'Avorio 20
AE - Emirati Arabi Uniti 19
EG - Egitto 16
RO - Romania 16
SA - Arabia Saudita 16
TN - Tunisia 15
ET - Etiopia 14
PH - Filippine 14
DK - Danimarca 13
LT - Lituania 13
DZ - Algeria 12
JO - Giordania 12
AZ - Azerbaigian 11
HU - Ungheria 11
KZ - Kazakistan 11
NP - Nepal 11
BO - Bolivia 10
CH - Svizzera 10
MY - Malesia 10
PY - Paraguay 10
JM - Giamaica 9
EU - Europa 8
DO - Repubblica Dominicana 7
AL - Albania 6
EE - Estonia 6
GR - Grecia 6
IL - Israele 6
IR - Iran 6
PT - Portogallo 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
KG - Kirghizistan 5
LV - Lettonia 5
NO - Norvegia 5
QA - Qatar 5
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
GT - Guatemala 4
HN - Honduras 4
LB - Libano 4
LU - Lussemburgo 4
PE - Perù 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
UY - Uruguay 4
AM - Armenia 3
BB - Barbados 3
MD - Moldavia 3
MN - Mongolia 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
BN - Brunei Darussalam 2
CG - Congo 2
GA - Gabon 2
HR - Croazia 2
Totale 43.801
Città #
Southend 2.847
Menlo Park 2.481
Dallas 2.169
Dublin 1.924
Singapore 1.541
Chandler 1.184
Ashburn 1.096
Fairfield 1.082
Jacksonville 1.041
Santa Clara 830
Beijing 812
Moscow 718
San Jose 698
Milan 634
Hong Kong 584
Wilmington 539
Hefei 526
Woodbridge 510
Ann Arbor 500
Seoul 447
Cambridge 406
Houston 405
Seattle 401
Nanjing 355
Princeton 339
Siena 314
The Dalles 289
Los Angeles 239
Council Bluffs 238
Helsinki 234
Rome 209
Ho Chi Minh City 208
Lauterbourg 190
New York 190
Boardman 179
Johannesburg 163
Munich 152
Hanoi 144
Buffalo 120
Nanchang 115
Orem 97
San Mateo 97
São Paulo 87
San Diego 84
Shanghai 84
Shenyang 80
Dearborn 71
London 64
Tianjin 64
Figino 63
Frankfurt am Main 58
Kunming 58
Chennai 56
Tokyo 53
Changsha 52
Hebei 52
Turku 52
Bengaluru 49
Redondo Beach 49
Florence 48
Jiaxing 47
Fremont 45
Düsseldorf 44
Redwood City 44
Turin 42
Dong Ket 41
Manchester 41
Warsaw 39
Da Nang 38
Chicago 37
Phoenix 37
Brooklyn 36
Málaga 36
Norwalk 36
Montreal 35
San Francisco 35
Jinan 34
Columbus 33
Toronto 33
Amsterdam 32
Atlanta 32
Izmir 31
Zhengzhou 31
Guangzhou 30
Rio de Janeiro 30
Washington 30
Venezia 29
Abuja 28
Hangzhou 28
Ningbo 27
Brussels 26
Prato 26
Belo Horizonte 25
Dhaka 25
Haiphong 25
Stockholm 25
Olomouc 24
Tashkent 23
Denver 22
Renton 22
Totale 29.675
Nome #
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 406
Different adaptive responses to hypoxia in normal and multiple myeloma endothelial cells 373
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 371
The Shc protein RAI promotes an adaptive cell survival program in hypoxic neuroblastoma cells 334
Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells 325
Administration of interferons and interleukin 2 via the lymphatic route 310
Adaptative cellular responses to hypoxia: role of HIF-1 dependent genes in endothelial cell autophagy and survival 310
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl 307
Analysis of protease-activated receptor-1 and -2 in human scar formation 301
Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway 300
Design, synthesis, biological activity and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study 299
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells 290
Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 289
Concentrazioni plasmatiche e tissutali di interferone in pazienti sottoposti a resezione chirurgica per cancro polmonare 286
A Ribonuclease Protection Assay-Based Approach for Analysis of Angiogenic Gene Expression in Archival Tissues 283
The Shc protein Rai enhances T-cell survival under hypoxia 280
Cell growth inhibition by interferon in hypoxia 278
Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma 271
Administration of the interferons via the lymphatic route 268
Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks 267
Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells 267
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs 266
Hydroxylase Inhibition Selectively Induces Cell Death in Monocytes 264
Thrombin regulates the expression of pro-angiogenic cytokines via proteolytic activation of protease-activated receptor-1 263
Fisiologia Renale in Fisiologia Medica di Ganong 13 edizione italiana 262
Neuroglobin in Breast Cancer Cells: Effect of Hypoxia and Oxidative Stress on Protein Level, Localization, and Anti-Apoptotic Function 261
The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells 257
Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes 256
Effects of astrocytoma cells conditioned medium on differentiated neuroblastoma cells subjected to hypoxia and reperfusion 256
L'ipossia induce l'espressione del recettore attivato da proteasi-1(PAR-1) nelle cellule MDA-MB-231 mediante l'accumulo del fattore indotto dall'ipossia-1alfa 255
Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells 255
Alanine kinetics in humans during low-intensity exercise 254
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 251
Bulk preparation of hepatic binding protein 250
Hypoxia and immune surveillance: role of the adaptor protein p66ShcA in negative regulation of T-cell activation and survival ' 248
Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration 248
Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors 246
Colorectal administration of human interferon -alpha 245
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1α and lipopolysaccharide 244
Hypoxia Shapes Autophagy in LPS-Activated Dendritic Cells 244
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype 240
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 234
Interleukin 10 production in patients undergoing cardiopulmonary bypass: evidence of inhibition of th-1-type responses 233
Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1 232
In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass 231
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes 231
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 229
Role of inflammatory mediators in angiogenesis 228
Analysis of HIF-1 alpha and HIF-2 alpha in dendritic cells stimulated under hypoxic conditions 227
Pyrazolo[3,4-d]pyrimidines Endowed with Antiproliferative Activity on Ductal Infiltrating Carcinoma Cells 227
Hypoxia induces the expression and release of interleukin 1 receptor antagonist in mitogen-activated mononuclear cells 226
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases 225
Pro·angiogenic signaling in neuroblastoma: interplay between HIF-1a and Shc C adaptor protein 224
GM-CSF inhibits c-Kit and SCF expression by bone marrow-derived dendritic cells 222
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 221
Different expression of cytokines and receptors in bleomycin-sensitive and resistant mice 219
Thrombin inhibits IFN-gamma production in human peripheral blood mononuclear cells by promoting a Th2 profile 218
The possible role of T cells and neutrophils in the regulation of tumour angiogenesis 218
Plasma levels of immunosuppressive mediators during cardiopulmonary bypass 218
‘HIF-1 dependent adaptative responses to hypoxia: pro-survival and pro-apoptotic signaling pathways 218
Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells 217
HIF-1 upregulation by IL-1 contributes to the migratory potential of breast cancer cells 217
Plasma kinetics, distribution and fate of tumor necrosis factor 217
Regulation of angiogenesis by Th1- and Th2-type cytokines 217
Interferon (IFN) levels in human pulmonary tumors 215
The effects of autologous platelet gel on inflammatory cytokine response in human peripheral blood mononuclear cells 214
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1alpha in breast cancer cells 209
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses 209
Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism 209
Alpha-thrombin reverses differentiation-related changes in expression of P21CIP1/WAF1 in interferon-gamma differentiated monocytic cells 209
Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression 206
Thrombin enhances T cell proliferative responses and cytokine production 206
Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1αand NFκB Transcription Factors 206
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia 205
Structure-Based Optimization of Pyrazolo[3,4-d]pyrimidines as Abl Inhibitors and Antiproliferative Agents toward Human Leukemia Cell Lines. 205
CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients 204
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells 203
Pharmacokinetics of human lymphoblastoid interferon in rabbits 202
Hypoxia triggers autophagy in human monocyte-derived dendritic cells 200
Human alpha-Thrombin Stimulates Proliferation of Interferon-gamma Differentiated, Growth-Arrested, U937 Cells, Overcoming Differentiation-Related Changes in Expression of p21CIP1/WAF1 and Cyclin D1 199
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 199
Role of p52RAI Shc protein in the adaptive response to hypoxia in T cells 199
Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors 198
Targeting hypoxia signaling pathways in angiogenesis 197
Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation 197
p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells 196
Hypoxia induces the expression of protease-activated receptor (PAR)-1 through the hypoxic inducible factor (HIF)-1α in MDA-MB-231 breast cancer cells 196
Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations 196
Hypoxia induces autophagy in human monocyte-derived dendritic cells: involvement of Class III PI3K/VPS34 195
Cytokine expression in bleomycin-sensitive and resistant mice 195
Role of the Hypoxia-Inducible Factor-1alpha and Akt on hypoxia-induced migratory program in dendritic cells 195
The thrombin peptide, TP508, enhances cytokine release and activates signaling events 195
Human alpha-thrombin as a growth factor: enhancement of T lymphocyte proliferative responses 194
SQSTM1/p62 inhibition impairs pro-survival signaling in hypoxic human dendritic cells 193
Angiogenesis in tissue hypoxia 193
Thrombin modulation of natural killer activity in human peripheral lymphocytes 193
Hypoxia induces coordinated adaptive responses in SK-N-MC neuronal cells towards a pro-angiogenic and migratory phenotype 193
Interferon levels in human pulmonary tumors are lower than plasma levels 192
Regulation of the hypoxia-inducible factor (HIF)-1α by interleukin-1: implication for breast cancer cell migration in the tumor microenvironment 192
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach 190
Totale 23.828
Categoria #
all - tutte 129.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.422 153 303 138 263 112 35 105 188 117 232 189 587
2022/20234.268 264 265 652 625 450 851 62 332 475 69 145 78
2023/20242.817 115 71 236 127 111 762 1.004 102 14 49 30 196
2024/20255.722 134 336 539 272 777 256 130 335 448 202 608 1.685
2025/202614.065 1.062 2.000 1.723 1.413 2.672 469 1.462 430 628 784 242 1.180
2026/2027305 305 0 0 0 0 0 0 0 0 0 0 0
Totale 44.004